Skip to main content
Premium Trial:

Request an Annual Quote

CLC Bio Projects Increased Sales and New Hires in 2011


CLC Bio said this week that it expects to see continued growth in product sales and to add to its employee headcount in 2011.

The company said that it generated more than $10 million in sales for the first time in 2010, marking a "respectable" year-over-year increase of 64 percent. This follows a 130 percent increase in sales for 2009 over 2008.

The company did not provide additional details about its revenues.

CLC Bio CEO Thomas Knudsen said that that the firm currently has nearly 1,000 customers and a positive cash flow, which it will use to "accelerate" product development and "expand" its market coverage in the new year.

Lasse Gorlitz, CLC Bio's director of communications, added that the company's clientele includes companies in pharmaceutical, agricultural, and biotechnology industries. He added that CLC Bio saw a "dramatic increase" in sales of its enterprise offerings, which come with hardware, to groups in these industries during 2010.

In addition to growing sales, CLC Bio increased its staff by more than 25 percent in 2010, bringing the total company headcount to 60 employees worldwide. The company said it plans to hire additional staff in 2011.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.